Adeona Pharmaceuticals to Present At Rodman & Renshaw Healthcare Conference
November 04, 2008 08:30 ET
|
Adeona Pharmaceuticals, Inc.
ANN ARBOR, Mich., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Adeona Pharmaceuticals, Inc. (AMEX:AEN), a late-stage specialty pharmaceutical company developing innovative candidates for the treatment of...
Adeona Pharmaceuticals' Oral dnaJP1 Phase II Clinical Findings Presented At the American College of Rheumatology Annual Meeting
October 28, 2008 08:59 ET
|
Adeona Pharmaceuticals, Inc.
ANN ARBOR, Mich., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Adeona Pharmaceuticals, Inc. (AMEX:AEN), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
Pipex Pharmaceuticals, Inc. Completes Corporate Name Change to Adeona Pharmaceuticals and Receives New Ticker Symbol
October 16, 2008 08:45 ET
|
Adeona Pharmaceuticals, Inc.
ANN ARBOR, Mich., Oct. 16, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (the "Company" or "Pipex") (AMEX:PP), a pharmaceutical company developing innovative late-stage oral drug candidates for...
Pipex Pharmaceuticals' Oral Flupirtine Receives IRB Approval to Initiate Phase II Clinical Trial for Fibromyalgia
October 07, 2008 08:29 ET
|
Adeona Pharmaceuticals, Inc.
ANN ARBOR, Mich., Oct. 7, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (AMEX:PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...